InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by LEIDEN JEFFREY M, Président Exécutif. Officer active across 1 company, notably Vertex Pharmaceuticals INC / MA. In total, 5 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €4.2m. History available since 1 February 2022. The latest transaction was filed on 13 April 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations5 total
15,789 shares@ US$289.040.0038% mcap50.3% of flowCommon StockSEC:0000899243-22-014805:0
12,141 shares@ US$227.860.0022% mcap29.4% of flowCommon StockSEC:0000899243-22-008119:0
8,236 shares@ US$232.510.0015% mcap20.2% of flowCommon StockSEC:0000899243-22-007209:0
28,444 shares0Common StockSEC:0001209191-22-006779
28,444 shares0Common StockSEC:0001209191-22-006779:0
5 of 5 declarations
About LEIDEN JEFFREY M
Jeffrey M. Leiden serves as Executive Chairman of Vertex Pharmaceuticals Inc. / MA. In this role, he oversees the company's overall strategy and ensures innovation in the biopharmaceutical sector. Leiden brings extensive experience in management and product development, which is essential for Vertex's growth. His commitment to excellence and strategic vision are assets to the board.
